Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Ulcerative Colitis
25000 people to benefit after NICE recommends new ulcerative colitis treatment – NICE
Posted: Published on March 15th, 2024
Thousands of people could be set to benefit after NICE today (Monday, 11 March) recommended a new one-a-day pill as an option for treating severe ulcerative colitis. NICEs final guidance on etrasimod (also known as Velsipity and made by Pfizer) is being published on the same day that the treatment was granted a licence by the Medicines and Healthcare Products Regulatory Agency (MHRA). Just over 25,000 people in England are eligible to receive the new treatment, which was evaluated using a simpler technology appraisal process. Continue reading
Posted in Ulcerative Colitis
Comments Off on 25000 people to benefit after NICE recommends new ulcerative colitis treatment – NICE
NICE recommends new ulcerative colitis treatment for NHS use – Nursing Times
Posted: Published on March 15th, 2024
A new once-a-day pill has been recommended as an option for treating severe ulcerative colitis in England, with thousands of patients set to be eligible. The National Institute for Health and Care Excellence (NICE) has published final guidance backing the treatment etrasimod (Velsipity) We are determined to continue getting the best care to patients fast Helen Knight The move, on Monday, came on the same day that etrasimod was granted a licence by the Medicines and Healthcare Products Regulatory Agency (MHRA). Continue reading
Posted in Ulcerative Colitis
Comments Off on NICE recommends new ulcerative colitis treatment for NHS use – Nursing Times
EU Commission Okays Pfizer’s VELSIPITY for Severe Ulcerative Colitis – Mirage News
Posted: Published on March 15th, 2024
Pfizer Inc. Continue reading
Posted in Ulcerative Colitis
Comments Off on EU Commission Okays Pfizer’s VELSIPITY for Severe Ulcerative Colitis – Mirage News
Etrasimod positive opinion for ulcerative colitis upgraded to approval in EU – Hospital Healthcare
Posted: Published on February 28th, 2024
Etrasimod (brand name Velsipity) has been granted marketing authorisation by the European Commission (EC) for use in eligible patients with ulcerative colitis (UC), its manufacturer Pfizer has announced. It is approved to treat patients aged 16 years and older with moderately to severely active UC who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biological agent. Continue reading
Posted in Ulcerative Colitis
Comments Off on Etrasimod positive opinion for ulcerative colitis upgraded to approval in EU – Hospital Healthcare
Prolonged culturing of colonic epithelial organoids derived from healthy individuals and ulcerative colitis patients … – Nature.com
Posted: Published on February 28th, 2024
Patient cohort description and pathology classification The present study was approved by the Kaunas Regional Biomedical Research Ethics Committee (Protocol No. BE-2-31) and written informed consent was obtained from each subject who participated in the study. All research was performed in accordance with relevant guidelines and regulations.This study consisted of three age- and sex-matched groups (Fig.4) Continue reading
Posted in Ulcerative Colitis
Comments Off on Prolonged culturing of colonic epithelial organoids derived from healthy individuals and ulcerative colitis patients … – Nature.com
Will smart tech revolutionise drug delivery for ulcerative colitis patients? – Pharmaceutical Technology
Posted: Published on February 28th, 2024
The NaviCap targeted oral delivery platform, is an ingestible device approximately the size of a fish oil pill. Credit: Andrea Danti via Shutterstock. Therapies within the ulcerative colitis (UC) space are ever-evolving for the improvement of local, targeted therapy. Continue reading
Posted in Ulcerative Colitis
Comments Off on Will smart tech revolutionise drug delivery for ulcerative colitis patients? – Pharmaceutical Technology
Biora Therapeutics completes first study phase for UC treatment By Investing.com – Investing.com
Posted: Published on February 28th, 2024
SAN DIEGO - Biora Therapeutics, Inc. (NASDAQ:BIOR), a biotech firm focused on innovative therapeutic delivery, has announced the completion of the single-ascending dose (SAD) cohorts in its phase 1 clinical trial of BT-600, a novel drug-device combination aimed at treating moderate to severe ulcerative colitis. The company is preparing to commence the multiple-ascending dose (MAD) cohorts in March, with expectations to share SAD data during its corporate update the same month Continue reading
Posted in Ulcerative Colitis
Comments Off on Biora Therapeutics completes first study phase for UC treatment By Investing.com – Investing.com
New Research Study for Patients With Ulcerative Colitis Now Available in Ogden, Utah – Chronicle-Tribune
Posted: Published on February 28th, 2024
State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington Washington D.C. Continue reading
Posted in Ulcerative Colitis
Comments Off on New Research Study for Patients With Ulcerative Colitis Now Available in Ogden, Utah – Chronicle-Tribune
Mood boosters reduce inflammation in IBD by 18%, study finds – News-Medical.Net
Posted: Published on January 27th, 2024
New King's College London research reveals that interventions which improve mood can reduce levels of inflammation in people with inflammatory bowel disease by 18 per cent, compared to having no mood intervention. Researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London found that interventions designed to improve mood, including psychological therapy, antidepressants, and exercise, were associated with significant reductions in inflammatory biomarker levels in individuals with inflammatory bowel disease (IBD). Continue reading
Posted in Ulcerative Colitis
Comments Off on Mood boosters reduce inflammation in IBD by 18%, study finds – News-Medical.Net